V
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A20.7 KBVIROPHARMA INCNov 9, 12:31 PM ET·0001050442-05-000035
- 8-K12.9 KBVIROPHARMA INCJul 13, 3:45 PM ET·0001181431-05-040017
- 8-K23.9 KBVIROPHARMA INCJun 20, 1:48 PM ET·0001181431-05-035548
- SC 13G/A45.8 KBVIROPHARMA INCMay 3, 2:40 PM ET·0000943663-05-000281
- 8-K49.4 KBVIROPHARMA INCApr 8, 11:58 AM ET·0001193125-05-072669
- SC 13G44.4 KBVIROPHARMA INCMar 29, 5:04 PM ET·0000950134-05-006248
- 8-K13.0 KBVIROPHARMA INCMar 29, 4:46 PM ET·0001193125-05-063476
- 8-K95.9 KBVIROPHARMA INCJan 25, 4:08 PM ET·0001193125-05-011384
- 8-K384.7 KBVIROPHARMA INCJan 13, 5:07 PM ET·0001193125-05-006010
- SC 13G42.0 KBVIROPHARMA INCDec 29, 1:49 PM ET·0000943663-04-000518
Insiders
10- Baker Biotech Capital (GP), LLC10% Owner
- Baker Biotech Capital II (GP), LLC10% Owner
- Baker Bros. Capital (GP), LLC10% Owner
- BAKER FELIX10% Owner
- BAKER JULIAN10% Owner
- Baker / Tisch Capital (GP), LLC10% Owner
- Broom Colin MDVP & Chief Scientific Officer
- COLLETT MARCVP, Drug Discovery
- DE ROSEN MICHELDirector, Chief Executive Officer
- DOYLE THOMAS FVP, General Counsel
Tickers
No tickers on record
Addresses
business
730 STOCKTON DRIVE
EXTON, PA, 19341
mailing
730 STOCKTON DRIVE
EXTON, PA, 19341